Cargando…
Uncontrolled Extensions of Clinical Trials and the Use of External Controls—Scoping Opportunities and Methods
Increased interest in real‐world evidence (RWE) for clinical and regulatory decision making and the need to evaluate long‐term benefits and risks of pharmaceutical products raise the importance of understanding the use of external controls (ECs) for uncontrolled extensions of randomized controlled t...
Autores principales: | Wang, Ching‐Yu, Berlin, Jesse A., Gertz, Barry, Davis, Kourtney, Li, Jie, Dreyer, Nancy A., Zhou, Wei, Seeger, John D., Santanello, Nancy, Winterstein, Almut G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290853/ https://www.ncbi.nlm.nih.gov/pubmed/34165790 http://dx.doi.org/10.1002/cpt.2346 |
Ejemplares similares
-
Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials
por: Seeger, John D., et al.
Publicado: (2020) -
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Suruki, Robert Y, et al.
Publicado: (2022) -
Uncontrolled interventions during pandemics: a missed learning opportunity?
por: Arulkumaran, N., et al.
Publicado: (2020) -
COVID-19 Provides An Opportunity to Reassess How Frequent and How Extensive Elective Spine Surgery Should Be
por: Epstein, Nancy E.
Publicado: (2020) -
Uncontrolled Donation after Circulatory Death Only Lung Program: An Urgent Opportunity
por: Lazzeri, Chiara, et al.
Publicado: (2023)